CD38-specific hcAbs induced potent ADCC regardless of their epitope specificity, but failed to induce substantial CDC of tumor cell lines in vitro or primary MM cells ex vivo. CD38-specific hcAbs significantly reduced tumor growth in vivo and significantly prolonged survival of xenograft bearing mice. Here, CD38 is linked to neoplasm.